Revenue breakdown: Product Sales And Supportive Services (94.3%), Research And Development (5.7%).
8-K
SIGA Technologies, Inc. reported financial results for the three and twelve months ended December 31, 2025, with product sales of $88 million, total revenues of $94.6 million, operating income of $23.7 million, and net income of $23.3 million. The company received a $13 million international procurement order for oral TPOXX in January 2026 and secured $27 million in additional U.S. Government funding in 2025.